BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 29507232)

  • 1. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells.
    Oskarsson ME; Hermansson E; Wang Y; Welsh N; Presto J; Johansson J; Westermark GT
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2752-E2761. PubMed ID: 29507232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of exogenous sodium palmitate increases the IAPP/insulin mRNA ratio via GPR40 in human EndoC-βH1 cells.
    Krizhanovskii C; Fred RG; Oskarsson ME; Westermark GT; Welsh N
    Ups J Med Sci; 2017 Aug; 122(3):149-159. PubMed ID: 28980863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide.
    de Koning EJ; Morris ER; Hofhuis FM; Posthuma G; Höppener JW; Morris JF; Capel PJ; Clark A; Verbeek JS
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8467-71. PubMed ID: 8078905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
    Westermark P; Andersson A; Westermark GT
    Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.
    Aston-Mourney K; Hull RL; Zraika S; Udayasankar J; Subramanian SL; Kahn SE
    Diabetologia; 2011 Jul; 54(7):1756-65. PubMed ID: 21484213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo.
    Mo XD; Gao LP; Wang QJ; Yin J; Jing YH
    Lipids Health Dis; 2018 Mar; 17(1):42. PubMed ID: 29523142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
    Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
    Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.
    Tomita T
    Islets; 2012; 4(3):223-32. PubMed ID: 22847497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human IAPP amyloidogenic properties and pancreatic β-cell death.
    Fernández MS
    Cell Calcium; 2014 Nov; 56(5):416-27. PubMed ID: 25224501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
    Jeong HR; An SS
    Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.
    Aston-Mourney K; Zraika S; Udayasankar J; Subramanian SL; Green PS; Kahn SE; Hull RL
    J Biol Chem; 2013 Feb; 288(5):3553-9. PubMed ID: 23229548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The β-cell assassin: IAPP cytotoxicity.
    Raleigh D; Zhang X; Hastoy B; Clark A
    J Mol Endocrinol; 2017 Oct; 59(3):R121-R140. PubMed ID: 28811318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease.
    Oskarsson ME; Paulsson JF; Schultz SW; Ingelsson M; Westermark P; Westermark GT
    Am J Pathol; 2015 Mar; 185(3):834-46. PubMed ID: 25700985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia-related Bri2 BRICHOS is a versatile molecular chaperone that efficiently inhibits Aβ42 toxicity in Drosophila.
    Poska H; Haslbeck M; Kurudenkandy FR; Hermansson E; Chen G; Kostallas G; Abelein A; Biverstål H; Crux S; Fisahn A; Presto J; Johansson J
    Biochem J; 2016 Oct; 473(20):3683-3704. PubMed ID: 27514716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
    Jaikaran ET; Clark A
    Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
    O'Brien TD; Butler PC; Westermark P; Johnson KH
    Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transthyretin and amyloid in the islets of Langerhans in type-2 diabetes.
    Westermark GT; Westermark P
    Exp Diabetes Res; 2008; 2008():429274. PubMed ID: 18825272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction.
    Westwell-Roper CY; Ehses JA; Verchere CB
    Diabetes; 2014 May; 63(5):1698-711. PubMed ID: 24222351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.
    Akter R; Cao P; Noor H; Ridgway Z; Tu LH; Wang H; Wong AG; Zhang X; Abedini A; Schmidt AM; Raleigh DP
    J Diabetes Res; 2016; 2016():2798269. PubMed ID: 26649319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.
    Brender JR; Salamekh S; Ramamoorthy A
    Acc Chem Res; 2012 Mar; 45(3):454-62. PubMed ID: 21942864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.